Cancer Pain
📧 Sign up to get email alerts when something new happens for Cancer Pain.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2023-12-14FDA Approved: HYDROMORPHONE HYDROCHLORIDE — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved hydromorphone hydrochloride from Hikma Pharmaceuticals USA Inc. under Original Application NDA217812 for pain management.
-
FDA approval · 2023-12-11FDA Approved: FENTANYL SYSTEM — Supplemental Application (ALVOGEN)
FDA approves ALVOGEN's Supplemental Application for the FENTANYL SYSTEM (fentanyl) under ANDA202097, granting a supplemental approval to the…
-
FDA approval · 2023-12-08FDA Approved: FENTANYL TRANSDERMAL — Supplemental Application (SpecGx LLC)
FDA issued a supplemental approval for fentanyl transdermal product submitted by SpecGx LLC.
-
CLINICAL_TRIALS trial_result · 2023-09-28Clinical Trial Update: Benefits of Morphine Gel for Pain Reduction in Patients With Cancer Wounds [Phase 2]
Phase 2 clinical trial update assessing the benefits of morphine gel in reducing pain for cancer-related wounds.
-
CLINICAL_TRIALS trial_result · 2023-01-20Clinical Trial Update: Phase 3 Study on the Efficacy and Safety of Tanezumab in Patients With Cancer Pain Due to Bone Metastasis Who Are Taking Background Opioid Therapy [Phase 3]
Phase 3 study assessing tanezumab for cancer pain due to bone metastasis in patients on background opioids has completed with results posted…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2022-12-05Clinical Trial Update: Methadone for 'Adenocarcinopathic' Pain Treatment [Phase 3]
Phase 3 trial of methadone for cancer-related pain was withdrawn.
-
CLINICAL_TRIALS trial_result · 2022-04-12Clinical Trial Update: NanaBis™ an Oro-buccal Administered delta9-Tetrahydrocannabinol (d9-THC) & Cannabidiol (CBD) Medicine for the Management of Bone Pain From Metastatic Cancers [Phase 3]
Phase 3 clinical trial update for NanaBis, an oro-buccal d9-THC & CBD medicine for cancer-related bone pain; current status is unknown.
-
CLINICAL_TRIALS withdrawal · 2021-11-09Clinical Trial Update: Phase 3 Study to Assess Resiniferatoxin vs Standard of Care for the Treatment of Intractable Cancer Pain [Phase 3]
A Phase 3 trial evaluating resiniferatoxin for intractable cancer pain was withdrawn.
-
CLINICAL_TRIALS trial_result · 2021-09-28Clinical Trial Update: Continuous IntraVenous Infusion of Ketamine in Terminally Ill Cancer Patients [Phase 2]
Phase 2 trial evaluating continuous intravenous ketamine for refractory cancer pain in terminally ill patients.
-
CLINICAL_TRIALS trial_result · 2021-08-13Clinical Trial Update: Usefulness of Acetaminophen Associated With Strong Opioids for Acute Pain in Cancer Patients [Phase 4]
Phase 4 trial evaluating the usefulness of acetaminophen with strong opioids for acute pain in cancer patients has completed.
-
CLINICAL_TRIALS trial_result · 2021-06-25Clinical Trial Update: Protocol to Monitor the Neurological Development of Infants With Exposure in Utero From Birth to 15 Months in Tanezumab Clinical Studies [Phase 3]
A Phase 3 protocol update describes monitoring neurological development in infants exposed to tanezumab in utero from birth to 15 months in …
-
FDA approval · 2021-05-06FDA Approved: MITIGO — Supplemental Application (Piramal Critical Care, Inc.)
FDA approved a supplemental submission for MITIGO (morphine sulfate) by Piramal Critical Care, Inc., approving changes to an existing morphi…
-
CLINICAL_TRIALS trial_result · 2021-03-08Clinical Trial Update: PCA vs Non-PCA Intravenous Hydromorphone Titration for Severe Cancer Pain [Phase 3]
Phase 3 trial comparing patient-controlled analgesia vs non-PCA intravenous hydromorphone titration for severe cancer pain has completed.
-
CLINICAL_TRIALS withdrawal · 2021-03-08Clinical Trial Update: Change the Dose Frequency of Controlled-Release Oxycodone to Refractory Pain [Phase 4]
A Phase 4 trial evaluating a change in dosing frequency for controlled-release oxycodone in refractory cancer pain was withdrawn.
-
CLINICAL_TRIALS trial_result · 2021-03-05Clinical Trial Update: Intravenous vs Oral Analgesia in Cancer Patients With Severe Pain After Successful Titration [Phase 2]
Phase 2 clinical trial comparing intravenous versus oral analgesia in cancer patients with severe pain after successful titration has comple…
-
CLINICAL_TRIALS trial_result · 2021-02-02Clinical Trial Update: Effectiveness and Tolerance of Inhaled Fentanyl Aerosol (25µg/Dose) in Chinese Patients With Breakthrough Cancer Pain [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating the effectiveness and tolerance of an inhaled fentanyl aerosol (25 µg per dose) in Chinese patients wi…
-
CLINICAL_TRIALS withdrawal · 2020-12-10Clinical Trial Update: Nasal Fentanyl for Chronic Cancer Pain [Phase 3]
Phase 3 trial of nasal fentanyl for chronic cancer pain was withdrawn.
-
CLINICAL_TRIALS trial_result · 2020-08-31Clinical Trial Update: Opioid Titration With 12.5 ug/h Fentanyl Transdermal Patch vs Orally Morphine for Opioid-naïve Patients With Moderate Cancer Pain [Phase 3]
Phase 3 trial comparing 12.5 mcg/h fentanyl transdermal patch titration with oral morphine for opioid-naïve patients experiencing moderate c…
-
CLINICAL_TRIALS research · 2020-03-27Clinical Trial Update: Qualitative Study for Pain Measurement Using Innovative Health Technology
A completed qualitative study evaluating a new health technology for measuring pain, with results posted in 2020.
-
FDA label_change · 2019-10-07FDA Approved: MORPHINE SULFATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA documents a supplemental application for Morphine Sulfate by Hikma Pharmaceuticals USA Inc., likely related to labeling changes for the …
-
CLINICAL_TRIALS trial_result · 2019-06-11Clinical Trial Update: A Study to Evaluate Buprenorphine Transdermal Patch in Chinese Subjects With Moderate to Severe Chronic Cancer Pain [Phase 3]
A Phase 3 clinical trial evaluating a buprenorphine transdermal patch for moderate to severe cancer pain in Chinese subjects.
-
CLINICAL_TRIALS trial_result · 2018-11-19Clinical Trial Update: An Interventional Study for Patient With Cancer Pain to Evaluate the Efficacy and Safety of OxyNorm® Compared to Morphine Sulfate Through the IV Continuous Infusion. [Phase 4]
A Phase 4 interventional trial comparing OxyNorm to morphine sulfate via IV infusion in cancer pain patients has completed with results post…
-
CLINICAL_TRIALS trial_result · 2018-10-24Clinical Trial Update: A Study to Assess the Safety and Tolerability of Oxycodone Hydrochloride 50mg/mL Administered as an Infusion [Phase 3]
Phase 3 trial investigating safety and tolerability of high-dose oxycodone hydrochloride infusion; study terminated.
-
FDA approval · 2018-09-18FDA Approved: FENTANYL TRANSDERMAL — Supplemental Application (SpecGx LLC)
FDA approved a supplemental application for fentanyl transdermal submitted by SpecGx LLC.
-
FDA approval · 2018-09-18FDA Approved: FENTANYL SYSTEM — Supplemental Application (ALVOGEN)
FDA approved a supplemental application for the Fentanyl System by ALVOGEN, indicating continued authorization for this fentanyl transdermal…